Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Novo Nordisk Blames Compounders As It Cuts 2025 Forecast. But Shares Jump.
Novo Nordisk Blames Compounders As It Cuts 2025 Forecast. But Shares Jump. · Investor's Business Daily

In This Article:

Novo Nordisk stock jumped early Wednesday despite cutting its 2025 outlook due to what Novo says is illegal compounding of GLP-1 medicines.